SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4151Isis Chief Is Bullish On His Firm's Strategy, Outlook BY PETER BENESH INVESbob zagorin-7/28/2007
4150as far as elegance, you'd get an argument from the biologists on the IV threbob zagorin-7/27/2007
4149<over my head> Over my head too. But what does this guy know, he is at skenhott-7/27/2007
4148over my head but of interest to some of you perhaps.. rnaitherapeutics.blogspotbob zagorin-7/27/2007
4147short data for july (7/13/07). that's a lot of shorts and explains some of tbob zagorin-7/25/2007
4146Isis Pharmaceuticals Shares Jump Thursday July 19, 12:36 pm ET Isis Pharmaceuticbob zagorin-7/19/2007
414519-Jul-07 Jefferies & Co Initiated Buy 17 target....bob zagorin-7/19/2007
4144How far along are they to getting the T5000 approved for clinical use? If they cdamainman-7/18/2007
4143and here's the link for the conference Metabolic Diseases Drug Discovery Wobob zagorin-7/14/2007
4142and two more on monday.. i'm thinking they'll have apretty good audiencebob zagorin-7/14/2007
4141from the iv board a new isis presentation on monday.. July 16 presentation An bob zagorin-7/14/2007
4140and here's another update from montgomery.. ISIS Pharm well positioned follbob zagorin-7/10/2007
413909:40 am ISIS Pharm: Needham & Co upgrades Buy to Strong Buy. Target $16. NeIan@SI-7/9/2007
4138>>Isis to Receive $26.5 Million from Alnylam Monday July 9, 12:59 pm ET Ctuck-7/9/2007
4137Given ISIS' interest in ALNY, which includes stock, the Roche deal with ALNYtuck-7/9/2007
413606/ 25 & 26 /07 : Najarian points to ISIS Site is recap of the shows Mad MoMLD38-6/27/2007
4135Alnylam Announces Achievement of Key Milestone in Collaboration Agreement Wednesbob zagorin-6/27/2007
4134My gut reaction to preclinical work, especially from an RNAi company, is that itIan@SI-6/25/2007
4133Genaera claims to have the first PT1-B inhbitor that acts both "centrally atuck-6/25/2007
4132pretty exciting stuff....thanks for backstopping....bob zagorin-6/24/2007
4131Bob, Do you take weekends off? <G> ... or just avoid Preclinical progreIan@SI-6/24/2007
4130new buy rating with $16 price target. NEW YORK, June 22 (newratings.com) - Analbob zagorin-6/22/2007
4129ISIS Gets Approval for Potential Buyback of Intellectual Property ...BiotechnolMLD38-6/19/2007
4128important prep for partnership deal.. xml.10kwizard.combob zagorin-6/19/2007
4127also from IV thread.. Value Line on Isis The full page Value Line report on Isbob zagorin-6/18/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News